Exabis Library
Welcome to the e-CCO Library!
P312: Has IBD specialists’ awareness of biosimilar monoclonal antibodies changed? Results from a survey amongst ECCO members
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P312: Retrospective study using ultrasonography in predicting clinical relapse of Crohn's disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P312: The value of faecal biomarkers for screening small bowel inflammation in patients with Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P312: Trabecular bone score in patients with inflammatory bowel diseases
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P313 Time to second pouchitis episode in a Dutch academic cohort
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P313: Comparison of accelerated infliximab induction versus standard induction treatment in acute severe ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P313: Glycan antibodies and pANCA in newly diagnosed inflammatory bowel disease patients at presentation and during follow-up
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P313: Impact of upadacitinib on the general clinical condition of patients with Crohn’s disease (CD): data from the randomised CELEST study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P313: Long-term durability and safety of anti-TNF agents compared with change to a different mechanism of action as a second-line biological treatment after first anti-TNF failure in Crohn´s disease: results from the Andalusian CambiaCrohn study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P313: Steroid and opioid use among Crohn’s patients before and after initiation of ustekinumab
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P313: Understanding Inflammatory Bowel Disease patients' experiences, expectations, and insights in identifying and managing anxiety and depression.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P313: Within 6 months from COVID-19 BNT162b2 vaccine patients with Inflammatory Bowel Diseases treated with Anti-TNFα have significantly lower serologic responses
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P314 C-Reactive protein is associated with depression and anxiety in patients with inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P314: Elderly onset is associated with low efficacy of anti-TNF treatment in Bio-naïve IBD patients: A multicenter cohort study by the Osaka Gut Forum
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P314: Long-term fate of the excluded rectum in Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P314: Management of perianal disease in patients with Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P314: Microscopic appendicitis in ulcerative colitis: Feasibility of ultrasonographic diagnosis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P314: Proposal for an anti-tumour necrosis factor–exit strategy based on trough serum level
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P314: TNF gene activation used as criterion to discontinue biologic therapy – A patient series introducing the NovaPrime TNF kit
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM